Latest Asx Listing News

Audalia Resources has outlined a 24.2 million tonne Medcalf resource, a maiden 11.77 million tonne probable ore reserve and study economics of up to $227 million in NPV. But the ASX-listed developer also reported a $1.31 million loss, only $720,861 in cash and an auditor warning over its ability to continue as a going concern.

TrivarX has made Stabl-Im its central development bet, but the ASX-listed health technology company also reported an $8.76 million FY2026 loss and an auditor-flagged material uncertainty over its ability to continue without further funding. The planned Phase 1 study remains subject to regulatory, ethics and operational clearances.

eMetals has shifted its exploration focus from Uganda to a larger Utah tungsten project, where high-grade re-assays have set up a 17-hole drilling campaign. But the ASX-listed explorer ended the year with $1.79 million in cash, $1.40 million of deferred consideration and an auditor-highlighted material uncertainty over its ability to continue as a going concern.

Desane Group Holdings reported a sharp FY26 profit decline as lower property revaluation gains and higher finance costs overwhelmed largely stable rental income. The ASX-listed property group enters FY27 with more cash, conservative gearing and two developments that now need to convert asset value into earnings.

New Frontier Minerals advanced its copper and rare earths portfolio during FY2026, but the annual report highlights a material uncertainty over its ability to continue as a going concern. The company ended the year with $1.23 million in cash after a $2.25 million placement and ongoing exploration spending.

Viva Leisure used FY2026 to prove its existing club network could generate stronger returns without rapid expansion, lifting revenue 12.2% and underlying NPAT 46.4%. The ASX-listed fitness group is now preparing to accelerate openings while reviewing options for its faster-growing payments and technology business.

TradeWindow is targeting 13% to 18% revenue growth in FY27 and expects to approach EBITDA breakeven, while preparing to shift its primary listing from the NZX to the ASX. The freight software company also reported rising recurring revenue, stronger customer economics and NZ$4.0 million in cash at 30 June 2026.

Sea Forest has reported a sharp lift in SeaFeed revenue during its first full year as an ASX-listed company, but remains loss-making as it funds production and market expansion. The methane-reduction specialist ended FY26 with $27.8 million in cash and term deposits and no borrowings.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

Global X Nasdaq 100 Covered Call Complex ETF reported a sharp improvement in annual profit, helped by a swing to fair-value gains and continued investor applications. The ASX-listed feeder fund paid or accrued $2.731 million in distributions, but the result does not show whether investors achieved a positive total return after unit-price movements.

VanEck’s 13 ASX-listed ETFs produced sharply divergent FY2026 results, led by a $1.002 billion profit for Global Infrastructure and a $321.5 million gain for Gold Miners. Video Gaming and Esports moved the other way, reporting a $21.5 million loss, while International Wide Moat was subsequently overhauled and renamed.

Global X Hydrogen ETF reported a $33.5 million profit for the year to 30 June 2026, driven almost entirely by fair-value gains. But the ASX-listed fund has since seen its net asset value fall by more than 10% as hydrogen-related holdings weakened.